In 454 paired-end sequencing analysis (3, 8, or 20kb), has anyone found that the sequence on the left of the linker to be significantly shorter than the sequence on the right? Theoretically, a randomly sheared sample should generate reads with sequences of equal length, on average, on either side of the linker. However, I am seeing a bias for the linker to be located near the start of the read. Could the circular products be more prone to shearing at a site closer to the left side of the linker?
-
-
Your post made me check, but both for the two smaller datasets (bacterial genome 3kb old GS FLX and Titanium 8kb PE), and the larger one (eukaryotic genome Titanium 3kb, 8kb, 20kb) I don't see a significant difference between the length distributions of the left half and the right half.
Also, when I plot the position of the linker (I take the start position of the right half from the 454TrimStatus.txt as a proxy) and divide it by the original trimmed read length, there is no bias either... -
Thanks for checking! I'm curious, how are you shearing after circularization? Covaris or nebulization? Also, are you using carrier DNA? It shouldn't make a difference, I just want to rule anything put...Comment
-
In solexa sequencing, pair end library especially index PE, we also found that pollution of read1 adpter >>read2, i don‘t understand why?Comment
-
BTW, index mate pair library !Comment
-
We follow the standard protocols, so nebulization and carrier DNA.Originally posted by lzembek View PostComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment